| Zacks Company Profile for Pacific Biosciences of California, Inc. (PACB : NSDQ) |
|
|
| |
| • Company Description |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Number of Employees: 575 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $1.47 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 9,289,335 shares |
| Shares Outstanding: 300.08 (millions) |
| Market Capitalization: $441.12 (millions) |
| Beta: 2.16 |
| 52 Week High: $2.72 |
| 52 Week Low: $0.85 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
22.50% |
16.97% |
| 12 Week |
25.64% |
6.03% |
| Year To Date |
-19.67% |
-24.52% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
1305 O`BRIEN DRIVE
-
MENLO PARK,CA 94025
USA |
ph: 650-521-8000
fax: 302-636-5454 |
ir@pacb.com |
http://www.pacb.com |
|
|
| |
| • General Corporate Information |
Officers
Christian O. Henry - Director; President; Chief Executive Officer and I
John F. Milligan - Chairman
Michele Farmer - Vice President and Chief Accounting Officer
William W. Ericson - Director
Randall S. Livingston - Director
|
|
Peer Information
Pacific Biosciences of California, Inc. (ABMD)
Pacific Biosciences of California, Inc. (DMDS)
Pacific Biosciences of California, Inc. (CPWY.)
Pacific Biosciences of California, Inc. (EQUR)
Pacific Biosciences of California, Inc. (ECIA)
Pacific Biosciences of California, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 69404D108
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
|
|
Share - Related Items
Shares Outstanding: 300.08
Most Recent Split Date: (:1)
Beta: 2.16
Market Capitalization: $441.12 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.16 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.64 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 5.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/06/25 |
|
|
|
| |
